UCLA Journal of Radiation Oncology APRIL 2023 - Flipbook - Page 50
UCLA RADIATION ONCOLOGY JOURNAL
AWARDS, PUBLICATIONS,
AND GRANTS
Recent wins from the UCLA Department of Radiation Oncology
John Nikitas, MD (PGY-3) has two recent
publications:
The role of adaptive planning in margin-reduced,
MRI-guided stereotactic body radiotherapy to the
prostate bed following radical prostatectomy: Posthoc analysis of a phase II clinical trial, published in
Radiotherapy and Oncology.
Early Safety and Efficacy Profile of Homogeneously
Dosed Salvage Stereotactic Body Radiotherapy
(SBRT) for Intraprostatic Recurrences After Low
Dose Rate (LDR) Brachytherapy, publlished in
Clinical Genitourinary Cancer.
Clayton Smith, MD (PGY-4) has three recent first
author publications:
Patterns of Failure in Men with Radiorecurrent
Prostate Cancer: A Post-Hoc Analysis of Three
Prospective Ga-68-PSMA PET/CT Imaging Trials,
published in The Red Journal/International Journal
of Radiation Oncology, Biology, Physics.
Transcriptomic Heterogeneity in High-risk Prostate
Cancer and Implications for Extraprostatic Disease
at Presentation on Prostate-specific Membrane
Antigen Positron Emission Tomography, published
in European Urology Oncology.
Brief Report: Severe Pneumonitis After Combined
Thoracic Radiotherapy and Osimertinib, published
in JTO Clinical and Research Reports.
Cecil Benitez, MD, PhD, MS (PGY-3) was selected for
the ACRO GREC Policy Fellowship.
Michael Xiang, MD, PhD, has two new publications:
Identifying predictors of on-table adaptation for
pancreas stereotactic body radiotherapy (SBRT),
published in Clinical and Translational Radiation
Oncology. [Co-senior author with Dr. Ann Raldow]
Race-dependent association of clinical trial
participation with improved outcomes for high-risk
prostate cancer patients treated in the modern era,
published in Prostate Cancer Prostatic Dis. [Cosenior author with Dr. Amar Kishan]
Trudy Wu, MD (PGY-4) had three recent
publications:
Identifying predictors of on-table adaptation for
pancreas stereotactic body radiotherapy (SBRT),
published in Clinical and Translational Radiation
Oncology.
Established and new horizons in radiotherapy for
breast cancer, published in Therapeutic Advances in
Medical Oncology.
Safety and Efficacy Results from iSABR, a Phase
I Study of Stereotactic Ablative Radiotherapy
(SABR) in Combination with Durvalumab for EarlyStage Medically Inoperable Non-Small Cell Lung
Cancer (NSCLC), published in The Red Journal/
International Journal of Radiation Oncology,
Biology, Physics.
Clayton Smith, MD (PGY-4) was appointed Radiation
Oncology Representative on the ACR Resident and
Fellow Section Executive Committee (July 2023- June
2024). This Committee represents the members-intraining on the ACR Council helping to coordinate
responses to issues and events that affect trainees.
Beth Neilsen, MD, PhD (PGY-3) had her application
to participate in the B. Leonard Holman Research
Pathway accepted by the ABR in November. In
January, she began her dedicated research period.
For this research, she joined the Paul Boutros
laboratory. Subsequently, she applied for and
was awarded a training position within the UCLA
Biomedical Data Science Training Program for
Precision Health Equity (T15LM0139976) last
month.
Clayton Smith, MD (PGY-4) recently completed his
first trail marathon on Catalina Island.
50